Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity

P Feltz

P Feltz. Appl Neurophysiol. 1979.

. 1979;42(1-2):47-50.

doi: 10.1159/000102335.

P Feltz

No abstract available

Similar articles

Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons.
Cools AR, Jaspers R, Kolasiewicz W, Sontag KH, Wolfarth S. Cools AR, et al. Behav Brain Res. 1983 Jan;7(1):39-49. doi: 10.1016/0166-4328(83)90003-7. Behav Brain Res. 1983. PMID: 6297521 No abstract available.
Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
Dray A, Fowler LJ, Oakley NR, Simmonds MA, Tanner T. Dray A, et al. Neuropharmacology. 1977 Jul-Aug;16(7-8):511-8. doi: 10.1016/0028-3908(77)90010-7. Neuropharmacology. 1977. PMID: 199852 No abstract available.
[Stereotyped behavior and the nigro-strio-nigral system].
Arushanian EB. Arushanian EB. Zh Vyssh Nerv Deiat Im I P Pavlova. 1985 Sep-Oct;35(5):819-32. Zh Vyssh Nerv Deiat Im I P Pavlova. 1985. PMID: 2866641 Review. Russian. No abstract available.
The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
Sphelmann R. Sphelmann R. Trans Am Neurol Assoc. 1974;99:255-7. Trans Am Neurol Assoc. 1974. PMID: 4156892 No abstract available.
Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Wolfarth S. Wolfarth S. Pol J Pharmacol Pharm. 1976;28(5):469-93. Pol J Pharmacol Pharm. 1976. PMID: 796834 Review. No abstract available.